Takhzyro 150 MG
Ended Awarded
- Contract number
- 36C24526N0144
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI DDEVYUAXJ624
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $36,984
Award facts
- Contract value 100% obligated
- $36,984.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Brooks, KY 40109, USA
Award details come from SAM.gov/FPDS.
About this award
On November 7, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a firm fixed-price delivery order valued at $36,984.28 to Takeda Pharmaceuticals America Inc. for the supply of TAKHZYRO 150 MG, a specialized pharmaceutical treatment for hereditary angioedema. This delivery order represents a child contract under the GSA Pharmaceuticals and Drugs Schedule (FSS-61-IB) and carries an ultimate completion date of November 13, 2025. The award was made without a set-aside designation, consistent with Takeda's historical contracting pattern for specialized pharmaceutical products. The place of performance is Brooks, Kentucky.
Takeda Pharmaceuticals America Inc., a subsidiary of Japan-based Takeda Pharmaceutical Company Limited, is a leading supplier of advanced pharmaceutical products to federal healthcare systems. The company currently holds a substantial single-award Blanket Purchase Agreement with the VA National Acquisition Center valued at $131.04 million, running through July 2026, which includes TAKHZYRO among other critical specialty medications for rare diseases and complex medical conditions. This delivery order fulfills immediate supply needs for the VA's healthcare operations through the established GSA schedule framework.
Quick answers
Who was awarded contract 36C24526N0144?
36C24526N0144 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 7, 2025.
How much is contract 36C24526N0144 worth?
The government has obligated $36,984 on 36C24526N0144.
Is contract 36C24526N0144 an order under another contract?
Yes. 36C24526N0144 is a delivery order under V797D50492, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0144 competed?
The extent of competition for 36C24526N0144 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award